It is the murine ortholog of AKR1B10 that is a significantly upregulated gene in the livers of human MASH patients, and its pharmacological inhibitors of AKR1B8 significantly reduced the pathological features of MASH, such as steatosis, inflammation, and fibrosis in mouse [47]. The gene discussed is AKR1B10; the disease is steatosis.